Perception and attitude of Jordanian physicians towards complementary and alternative medicine (CAM) use in oncology

Complementary Therapies in Clinical Practice

Volumn 19, Issue 2, 2013, Pages 70-76

  Al Omari, Amal ^a   Al Qudimat, Mohammad ^a   Abu Hmaidan, Amid ^a   Zaru, Luna ^a  

^a KING HUSSEIN CANCER CENTER   (Jordan)

Author keywords

Attitudes; Complementary medicine; Herbal remedies; Oncology; Perception

Indexed keywords

ADULT; ALTERNATIVE MEDICINE; ARTICLE; ATTITUDE TO HEALTH; CHI SQUARE DISTRIBUTION; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; JORDAN; MALE; METHODOLOGY; MIDDLE AGED; ONCOLOGY; PHYSICIAN; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CHI-SQUARE DISTRIBUTION; CLUSTER ANALYSIS; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; JORDAN; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; PHYSICIANS; QUESTIONNAIRES;

EID: 84875804331     PISSN: 17443881     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctcp.2013.01.002     Document Type: Article

References (29)

1. CAM basics, What is complementary and alternative medicine? National Center for Complementary and Alternative Medicine:, [accessed April, 2012]. http://nccam.nih.gov.
2. Richardson M.A., Masse L.C., Nanny K., Sanders C. Discrepant views of oncologists and cancer patients on complementary/alternative medicine. Support Care Cancer 2004, 12:797-804.
3. Richardson M.A., Sanders T., Palmer J.L., Greisinger A., Singletary S.E. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000, 18:2505-2514.
4. Hyodo I., Amano N., Eguchi K., Narabayashi M., Imanishi J., Hirai M., et al. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol 2005, 23:2645-2654.
5. Oran S. Genetic resources of medicinal plants in Jordan. Plant genetic resources of Jordan. Proceedings of a national seminar. 2-4 August 1994 West Asia and North Africa Regional Office 1994, 13-51. IPGRI, Amman. A. Jaradat (Ed.).
6. Afifi F.U., Wazaify M., Jabr M., Treish E. The use of herbal preparations as complementary and alternative medicine (CAM) in a sample of patients with cancer in Jordan. Complement Ther Clin Pract 2010, 16:208-212.
7. Al-Qudimat M.R., Rozmus C.L., Farhan N. Family strategies for managing childhood cancer: using complementary and alternative medicine in Jordan. J Adv Nurs 2011, 67:591-597.
8. Richardson M., Straus S. Complementary and alternative medicine: opportunities and challenges for cancer management and research. Semin Oncol 2002, 29:531-535.
9. Conklin K. Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 2000, 37:1-18.
10. Lamson D., Brignall M. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern Med Rev 1999, 4:304-329.
11. Loos W., Sparreboom A. Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst 2002, 94:1247-1249.
12. Degner L.F., Sloan J.A. Decision making during serious illness: what role do patients really want to play?. J Clin Epidemiol 1992, 45:941-950.
13. Schofield P., Diggens J., Charleson C., Marigliani R., Jefford M. Effectively discussing complementary and alternative medicine in a conventional oncology setting: communication recommendations for clinicians. Patient Educ Couns 2010, 79:143-151.
14. Corbin Winslow L., Shapiro H. Physicians want education about complementary and alternative medicine to enhance communication with their patients. Arch Intern Med 2002, 162:1176-1181.
15. Akhu-Zaheya L.M., Alkhasawneh E.M. Complementary alternative medicine use among a sample of Muslim Jordanian oncology patients. Complement Ther Clin Pract 2011, 10.1016/j.ctcp.2011.10.003.
16. Astin J.A. Why patients use alternative medicine: results of a national study. JAMA 1998, 279:1548-1553.
17. Boon H., Stewart M., Kennard M.A., Gray R., Sawka C., Brown J.B., et al. Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 2000, 18:2515-2521.
18. Hyodo I., Eguchi K., Nishina T., Endo H., Tanimizu M., Mikami I., et al. Perceptions and attitudes of clinical oncologists on complementary and alternative medicine: a nationwide survey in Japan. Cancer 2003, 97(11):2861-2868.
19. Giveon S.M., Liberman N., Klang S., Kahan E. A survey of primary care physicians' perceptions of their patients' use of complementary medicine. Complement Ther Med 2003, 11(4):254-260.
20. Kim do Y., Kim B.S., Lee K.H., Lee M.A., Hong Y.S., Shin S.W., et al. Discrepant views of Korean medical oncologists and cancer patients on complementary and alternative medicine. Cancer Res Treat 2008, 40(2):87-92.
21. Slifman N.R., Obermeyer W.R., Aloi B.K., Musser S.M., Correll W.A., Cichowicz S.M., et al. Contamination of botanical dietary supplements by Digitalis lanata. N Engl J Med 1998, 339(12):806-811.
22. Ko R.J. Adulterants in Asian patent medicines. N Engl J Med 1998, 339(12):847.
23. LoVecchio F., Curry S.C., Bagnasco T. Butyrolactone-induced central nervous system depression after ingestion of RenewTrient, a "dietary supplement". N Engl J Med 1998, 339(12):847-848.
24. Chavez M.L., Jordan M.A., Chavez P.I. Evidence-based drug-herbal interactions. Life Sci 2006, 78(18):2146-2157.
25. Balis F.M. Pharmacokinetic drug interactions of commonly used anticancer drugs. Clin Pharmacokinet 1986, 11(3):223-235.
26. Cheng C.W., Fan W., Ko S.G., Song L., Bian Z.X. Evidence-based management of herb-drug interaction in cancer chemotherapy. Explore (NY) 2010, 6(5):324-329.
27. Roth M., Lin J., Kim M., Moody K. Pediatric oncologists' views toward the use of complementary and alternative medicine in children with cancer. J Pediatr Hematol Oncol 2009, 31(3):177-182.
28. Deng G.E., Frenkel M., Cohen L., Cassileth B.R., Abrams D.I., Capodice J.L., et al. Society for Integrative Oncology. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol 2009, 7(3):85-120.
29. Wesa K.M., Cassileth B.R. Introduction to section on integrative oncology. Curr Treat Options Oncol 2010, 11(3-4):70-72.